Choosing the right drug to fit the patient when selecting oral anticoagulation for stroke prevention in atrial fibrillation

Journal of Internal Medicine
A M Shields, Gregory Y H Lip

Abstract

Atrial fibrillation (AF) is the most common cardiac arrhythmia worldwide and is a growing health problem that is associated with a significantly increased risk of stroke and thromboembolism. Oral anticoagulant (OAC) therapy reduces the risk of stroke and all-cause mortality in patients with AF. OAC therapy is commonly given as a well-controlled vitamin K antagonist (VKA; e.g. warfarin) and can reduce the risk of stroke in AF patients by almost two-thirds. However, the widespread use of VKAs has been hampered by the unpredictable pharmacokinetic and pharmacodynamic properties of the drugs and justifiable concerns about the consequent risk of haemorrhage. The non-VKA OACs (NOACs) have revolutionized thromboprophylaxis in AF by providing therapeutic options with predictable pharmacodynamic and pharmacokinetic properties that are as efficacious as warfarin in the prevention of stroke and thromboembolism but are more convenient to use. In this review, we provide a patient-centred framework to assist clinicians in recommending the right OAC therapy to fit the individual patient with AF, including methods for stratifying the risk of stroke and haemorrhage and the chances of achieving tight control of VKA anticoagulation, and we discus...Continue Reading

References

Aug 1, 1991·Stroke; a Journal of Cerebral Circulation·P A WolfW B Kannel
Dec 14, 1996·BMJ : British Medical Journal·M LangenbergJ A Knottnerus
Apr 28, 1999·Archives of Internal Medicine·M Man-Son-HingA Laupacis
Jun 13, 2001·JAMA : the Journal of the American Medical Association·B F GageM J Radford
Apr 6, 2002·BMJ : British Medical Journal·Adrian EdwardsAl Mulley
Nov 19, 2002·JAMA : the Journal of the American Medical Association·Carl van WalravenBeppie Hellemons
May 25, 2005·Archives of Internal Medicine·Anne M HolbrookPhilip S Wells
Oct 6, 2005·European Heart Journal·Robby NieuwlaatUNKNOWN European Heart Survey Investigators
Mar 11, 2006·European Heart Journal·Jan HeeringaJacqueline C M Witteman
May 3, 2006·The American Journal of Medicine·Graham ThrallGregory Y H Lip
May 10, 2006·Journal of Thrombosis and Thrombolysis·Anders IngelgårdDavid Fitzmaurice
May 15, 2008·Cerebrovascular Diseases·UNKNOWN European Stroke Organisation (ESO) Executive Committee, UNKNOWN ESO Writing Committee
Jan 30, 2009·European Heart Journal·Leif FribergMårten Rosenqvist
Feb 3, 2009·Stroke; a Journal of Cerebral Circulation·Carl van WalravenDaniel E Singer
Apr 2, 2009·The New England Journal of Medicine·Stuart J ConnollySalim Yusuf
Sep 1, 2009·The New England Journal of Medicine·Stuart J ConnollyUNKNOWN RE-LY Steering Committee and Investigators
Sep 2, 2009·Annals of Internal Medicine·Daniel E SingerAlan S Go
Nov 26, 2009·The American Journal of Cardiology·Gerald V NaccarelliKathy L Schulman
Dec 19, 2009·Circulation·UNKNOWN WRITING GROUP MEMBERSUNKNOWN American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Dec 25, 2009·Circulation. Cardiovascular Quality and Outcomes·Yi WanYongyong Xu
Jan 1, 2010·The New England Journal of Medicine·Donald Stuart Houston, Ryan Zarychanski
Apr 28, 2010·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Etienne AliotUNKNOWN World Heart Federation
May 12, 2010·Thrombosis and Haemostasis·G Karthikeyan, J W Eikelboom
Sep 30, 2010·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·A John CammUNKNOWN ESC Committee for Practice Guidelines
Jan 19, 2011·British Journal of Clinical Pharmacology·Catherine J Lee, Jack E Ansell
Feb 12, 2011·The New England Journal of Medicine·Stuart J ConnollyUNKNOWN AVERROES Steering Committee and Investigators
Mar 26, 2011·Circulation Journal : Official Journal of the Japanese Circulation Society·Masatsugu HoriUNKNOWN RE-LY Investigators
May 5, 2011·Circulation. Cardiovascular Quality and Outcomes·Michael H KimKathy L Schulman

❮ Previous
Next ❯

Citations

Mar 17, 2016·EBioMedicine·Christos VoukalisEduard Shantsila
May 7, 2016·Cardiology Clinics·Marco Proietti, Gregory Y H Lip
Mar 24, 2016·Journal of Internal Medicine·G Y H LipC Blomström-Lundqvist
Aug 15, 2015·Journal of Comparative Effectiveness Research·Qinmei XiongGregory Y H Lip
Sep 1, 2016·Herzschrittmachertherapie & Elektrophysiologie·Thomas Maria HelmsJohann Christoph Geller
Oct 4, 2016·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Emanuel RaschiFabrizio De Ponti
Nov 5, 2016·Expert Review of Hematology·Martin ThoenesCarmen Ferrero
Jan 31, 2017·Basic & Clinical Pharmacology & Toxicology·Maja HellfritzschAnton Pottegård
Jan 11, 2017·British Journal of Clinical Pharmacology·Luca MonacoDomenico Motola
Aug 20, 2015·Vascular Medicine·Sara Vazquez, Matthew T Rondina
Oct 6, 2016·International Journal of Stroke : Official Journal of the International Stroke Society·Ayrton MassaroRoland Veltkamp
Nov 28, 2017·The Nurse Practitioner·Connie S Cole, Richard Zimmerman
Mar 3, 2018·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Maja HellfritzschAnton Pottegård
Feb 26, 2016·Journal of the American Heart Association·Xiaoxi YaoPeter A Noseworthy
Oct 20, 2018·International Journal of Clinical Practice·Gregory Y H Lip
May 10, 2016·Nature Reviews. Disease Primers·Gregory Y H LipDeirdre A Lane
Aug 9, 2017·Expert Opinion on Pharmacotherapy·Walter AgenoAndrea Rubboli
Sep 26, 2019·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Emanuel RaschiFabrizio De Ponti
Nov 16, 2017·Pharmacoepidemiology and Drug Safety·Anton PottegårdMaja Hellfritzsch
Jun 23, 2019·Journal of Clinical Medicine·Nijole BernaitisShailendra Anoopkumar-Dukie
Jul 1, 2020·Journal of Thrombosis and Thrombolysis·Olga GavínJuan José Cerezo-Manchado
Jan 26, 2021·Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association·Narong PuttasungNijole Bernaitis
Apr 26, 2021·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Jan SteffelUNKNOWN External reviewers
Nov 3, 2021·European Geriatric Medicine·M Cristina PolidoriUNKNOWN Special Interest Group “Cardiovascular Diseases” of the EuGMS

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Related Papers

Clinical Pharmacology and Therapeutics
Tatjana S Potpara, Gregory Y H Lip
Anadolu Kardiyoloji Dergisi : AKD = the Anatolian Journal of Cardiology
Alper Kepez, Okan Erdoğan
Trends in Cardiovascular Medicine
Mikhail S Dzeshka, Gregory Y H Lip
© 2022 Meta ULC. All rights reserved